h.bakker
TL2 Moderator · Lyon
Contributes reviews on supplier material. Based in Lyon.
Joined 20 October 2024 · last posted 2d · groups: translators
79 posts, newest first. Showing up to 150.
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #114 · Analytics › Impurities & related substances · 26 Jul 2026 · 26 likes Picking up post #111: that is the part I would want checked first. Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be…
-
What to bring: records that a clinician can actually use Replied, post #18 · Clinical › Prescriber conversations · 25 Jul 2026 · 26 likes This follows post #15 rather than contradicting it. Understanding stopping rules: what would prompt stopping the compound? Adverse effect, lack of benefit after a…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #74 · Practice › Side effects · 25 Jul 2026 · 10 likes This follows post #71 rather than contradicting it. Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe.…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #36 · Sourcing › Regulatory · 18 Jul 2026 · 28 likes Coming back to post #34, because the follow-up matters more than the original answer. Why this category is maintained as documentation, not as recommendations: the goal…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #41 · Practice › Reconstitution · 15 Jul 2026 · 16 likes This follows post #38 rather than contradicting it. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration…
-
Here for the analytics and not much else Replied, post #10 · Lounge › Introductions · 8 Jul 2026 · 11 likes This follows post #7 rather than contradicting it. Ongoing: you can post multiple introductions over time. If you return after a long break, reintroducing yourself is…
-
A single out-of-range value on an otherwise normal panel Replied, post #64 · Clinical › Bloodwork · 25 Jun 2026 · 28 likes On post #60 — agreed on the reasoning, with one qualification. Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A…
-
Follow-up: The retatrutide phase 2 obesity paper, read closely Replied, post #19 · Compounds › Retatrutide · 23 Jun 2026 · 1 like Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
-
Pages past their review date, listed — does this still hold? Replied, post #18 · Meta › Wiki maintenance · 20 Jun 2026 · 0 likes Cross-referencing: if two pages should reference each other but do not, suggesting the cross-reference helps the maintainer see the connection.
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #56 · Practice › Storage & stability · 5 Jun 2026 · 7 likes This follows post #53 rather than contradicting it. Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #37 · Access › Insurance & coverage · 1 Jun 2026 · 26 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
-
Follow-up: Search filters: what is missing Replied, post #107 · Meta › Site feedback · 20 May 2026 · 7 likes Bugs and friction: the parts of the site that do not work the way you expected. Report them specifically (what you did, what you expected, what happened instead) so…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #60 · Research Methods › N-of-1 designs · 24 Apr 2026 · 23 likes This follows post #57 rather than contradicting it. Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a defined number of…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #83 · Research Methods › Statistics · 20 Apr 2026 · 22 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Prescription requirements and telehealth models — a second dataset Replied, post #5 · Sourcing › Regulatory · 17 Apr 2026 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #8 · Analytics › Home & field testing · 9 Apr 2026 · 26 likes What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It…
-
What changed in 2026, by region — does this still hold? Replied, post #2 · Access › International · 8 Apr 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
A checklist for reading a certificate in under two minutes Replied, post #3 · Analytics › COA interpretation · 8 Apr 2026 · 6 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Joined after a search result and stayed Replied, post #2 · Lounge › Introductions · 4 Apr 2026 · 11 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #18 · Analytics › Mass spectrometry · 19 Mar 2026 · 6 likes Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply charged at ≈ 1371, quadruply at ≈ 1029. Those are the positions…
-
A parcel stationary at a customs facility for nine days Replied, post #38 · Sourcing › Logistics · 14 Mar 2026 · 4 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…
-
Angle of injection and whether 90 degrees is always right Replied, post #115 · Practice › Administration · 12 Mar 2026 · 19 likes post #114 answers the question as asked. The question underneath it is different. A genuinely late dose: the labelling generally says that if the next dose is more than…
-
System suitability injections: if they failed, the run did not happen — the long version Started this topic · Analytics › HPLC & UHPLC · 7 Mar 2026 · 0 likes System suitability injections: if they failed, the run did not happen — the long version — setting out what I have, and where I think it stops being reliable. A…
-
The lowest dose that does anything: is that a real question? Replied, post #48 · Practice › Dosing & titration · 4 Mar 2026 · 11 likes On post #44 — agreed on the reasoning, with one qualification. When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent…
-
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #12 · Compounds › Cagrilintide & amylin analogues · 28 Feb 2026 · 8 likes Coming back to post #10, because the follow-up matters more than the original answer. Cagrilintide molecular characteristics: it is a synthetic amylin analogue,…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #25 · Sourcing › Vendor reports · 20 Feb 2026 · 4 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Follow-up: An emergency department visit, described afterwards Started this topic · Safety › Adverse events · 18 Feb 2026 · 7 likes On the subject in the title: An emergency department visit, described afterwards Working notes rather than a conclusion. General question, not a request for advice…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #16 · Analytics › Impurities & related substances · 10 Feb 2026 · 6 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #77 · Sourcing › Red flags · 4 Feb 2026 · 27 likes This follows post #74 rather than contradicting it. Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's…
-
Run-in periods and the population they select Replied, post #48 · Evidence › Trials · 10 Jan 2026 · 6 likes Worth separating two things that post #44 runs together. Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it…
-
Whether protein timing matters at a large deficit Replied, post #13 · Nutrition & Training › Protein & intake · 1 Jan 2026 · 2 likes Worth separating two things that post #9 runs together. Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #16 · Data & Tools › Calculators · 6 Dec 2025 · 13 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
-
Compounds this community declines to help with, and why Replied, post #78 · Compounds › Other compounds · 7 Oct 2025 · 6 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
-
A genuinely late dose: what the labelling says and what people do — what changed since Started this topic · Practice › Administration · 1 Oct 2025 · 6 likes A genuinely late dose: what the labelling says and what people do — what changed since — setting out what I have, and where I think it stops being reliable. I have read…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #23 · Lounge › Off topic · 6 Sep 2025 · 11 likes Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of other communities. Just a relaxed bar for how directly the topic needs to…
-
Appeal templates and why they are deliberately unemotional Replied, post #13 · Access › Insurance & coverage · 1 Sep 2025 · 18 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Checking someone else's arithmetic: a worked example thread Replied, post #79 · Practice › Reconstitution · 19 Aug 2025 · 16 likes This follows post #76 rather than contradicting it. Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and…
-
A request that was declined, and the reasoning — a second dataset Replied, post #20 · Documentation › Wiki requests · 7 Aug 2025 · 0 likes On post #16 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #79 · Compounds › Repair & healing peptides · 4 Aug 2025 · 13 likes Coming back to post #77, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #65 · Evidence › Trials · 30 Jul 2025 · 0 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Temperature loggers worth the money — the long version Replied, post #16 · Devices › Cold chain · 26 Jul 2025 · 13 likes post #15 answers the question as asked. The question underneath it is different. Temperature logging: devices that record temperature over time let you confirm cold…
-
A field-by-field walk through a certificate of analysis Replied, post #33 · Analytics › COA interpretation · 15 Jul 2025 · 2 likes Coming back to post #31, because the follow-up matters more than the original answer. Counter-ion form is crucial: peptides are isolated as salts, most often…
-
What this community means by "a source", in practical terms Replied, post #15 · Start Here › Welcome · 25 Jun 2025 · 0 likes Worth separating two things that post #11 runs together. Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #64 · Compounds › Retatrutide · 13 Jun 2025 · 28 likes Worth separating two things that post #60 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #32 · Compounds › Cagrilintide & amylin analogues · 7 Jun 2025 · 15 likes Coming back to post #30, because the follow-up matters more than the original answer. Reading the phase 2 paper: it establishes tolerability and efficacy in a selected…
-
Coming back to: Getting a referral rather than a refusal Replied, post #23 · Clinical › Prescriber conversations · 2 Jun 2025 · 20 likes post #22 is right about the mechanism and I think understates the practical bit. Clarifying indication: if a compound is approved for diabetes but you have obesity…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #62 · Practice › Reconstitution · 1 Jun 2025 · 0 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
Titles that describe the question, not the situation Replied, post #16 · Start Here › How to Ask · 25 May 2025 · 32 likes What you have already read matters. Saying "I read the maintained page on this and I still have a gap" tells people they do not need to point you at the same resource…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #96 · Practice › Interactions · 22 May 2025 · 5 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
Coming back to: Official shortage notices and what they authorise Replied, post #9 · Access › Shortages · 18 May 2025 · 6 likes Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #47 · Wellbeing › Mental health · 8 May 2025 · 7 likes Identity and self-image: for some people, weight and body size are central to identity. Large change to body size can affect identity. This is not pathological; it is…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #39 · Compounds › Cagrilintide & amylin analogues · 7 May 2025 · 0 likes Worth separating two things that post #35 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #3 · Compounds › Oral incretins · 25 Apr 2025 · 17 likes Coming back to the opening post, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from…
-
Water content on a certificate and why it changes the arithmetic Replied, post #5 · Analytics › COA interpretation · 24 Apr 2025 · 5 likes I read post #3 twice before replying, because I had assumed the opposite. Reading old certificates: if a certificate is dated years ago, the lot it describes might be…
-
Coming back to: Column chemistry choices for a 40-residue peptide Replied, post #3 · Analytics › HPLC & UHPLC · 27 Mar 2025 · 13 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #42 · Compounds › Tirzepatide · 19 Mar 2025 · 2 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
Coverage for the indication versus for the drug — a second dataset Replied, post #24 · Access › Insurance & coverage · 17 Mar 2025 · 0 likes Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
-
Oxidation and deamidation mass shifts, tabulated Replied, post #67 · Analytics › Mass spectrometry · 7 Mar 2025 · 0 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
-
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #14 · Evidence › Journal club · 27 Feb 2025 · 7 likes post #13 answers the question as asked. The question underneath it is different. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #20 · Analytics › COA interpretation · 23 Feb 2025 · 0 likes post #19 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #7 · Access › Pricing · 10 Feb 2025 · 23 likes I read post #5 twice before replying, because I had assumed the opposite. Subscription services and subscriptions: some online clinics bundle compounds into…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #80 · Sourcing › Regulatory · 7 Feb 2025 · 1 like Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #45 · Clinical › Bloodwork · 5 Feb 2025 · 0 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #6 · Clinical › Comorbidities · 30 Jan 2025 · 0 likes Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without diabetes; SUSTAIN 6 was in high-risk diabetes. Absolute…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #5 · Practice › Reconstitution · 19 Jan 2025 · 0 likes post #4 is right about the mechanism and I think understates the practical bit. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives…
-
Transit times by route, from a logged dataset — the long version Replied, post #44 · Sourcing › Logistics · 30 Dec 2024 · 13 likes I read post #42 twice before replying, because I had assumed the opposite. Declaring contents accurately: declaring accurately reduces intervention risk. A declaration…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #31 · Wellbeing › Mental health · 26 Dec 2024 · 0 likes I read post #29 twice before replying, because I had assumed the opposite. Social and relationship impacts: weight change affects how others perceive and interact with…
-
Fixed versus detachable needles: the trade-offs Replied, post #57 · Devices › Syringes & needles · 18 Dec 2024 · 3 likes Worth separating two things that post #53 runs together. Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your…
-
Promotion criteria, and the one that stops most nominations Replied, post #117 · Documentation › Doc review · 19 Nov 2024 · 1 like Coming back to post #115, because the follow-up matters more than the original answer. Revision disputes: if you disagree with an edit a maintainer made to a page,…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #95 · Practice › Dosing & titration · 1 Nov 2024 · 3 likes post #94 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #46 · Access › Shortages · 10 Oct 2024 · 20 likes Picking up post #43: that is the part I would want checked first. Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #76 · Practice › Dosing & titration · 4 Oct 2024 · 19 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #25 · Compounds › Tirzepatide · 30 Sep 2024 · 2 likes I read post #23 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Started this topic · Compounds › Semaglutide · 17 Aug 2024 · 0 likes Posting this under the heading it deserves: Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Everything below is what sits behind…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #17 · Analytics › Mass spectrometry · 13 Aug 2024 · 30 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Reporting a discrepancy without making an allegation Replied, post #5 · Sourcing › Vendor reports · 26 Jul 2024 · 24 likes What "verified" means on our pages: specific lots were independently measured on stated dates by named services and results were consistent with the supplier's…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #48 · Compounds › Retatrutide · 19 Jul 2024 · 0 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #118 · Practice › Dosing & titration · 10 Jul 2024 · 1 like Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
Follow-up: Oral contraceptives and delayed emptying: what the data shows Replied, post #3 · Practice › Interactions · 18 Jun 2024 · 28 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…